文献速递神经MR

7 T磁共振波谱成像在多发性硬化中的应用:空间分辨率如何影响脑病灶代谢变化的检出

7 T Magnetic Resonance Spectroscopic Imaging in Multiple Sclerosis: How Does Spatial Resolution Affect the Detectability of Metabolic Changes in Brain Lesions?
PubMed 文献 · Invest Radiol · 2019-01-01

前瞻性纳入20例复发缓解型多发性硬化患者,比较3种空间分辨率自由感应衰减磁共振波谱成像对77个T2高信号病灶代谢模式的检出差异;超高分辨率(100×100,约2×2×8 mm体素)较最低分辨率(32×32)平均代谢比值高40%至80%、最大代谢比值增100%至150%,且83%病灶可辨肌醇/NAA升高而32×32仅35%,扫描时间6分钟。

要点

  • 超高分辨率MRSI(100×100矩阵,约2×2×8 mm体素)可在6分钟内检出常规分辨率无法识别的多发性硬化病灶代谢改变。
  • 100×100分辨率下83%的多发性硬化病灶显示肌醇/NAA升高,64×64为66%,32×32仅35%。
  • 100×100较32×32的平均代谢比值高40%至80%、最大代谢比值增100%至150%,同时信噪比>12、Cramér-Rao下界<20%。

核心结论

  • 约2×2×8 mm体素的超高分辨率MRSI可在临床可接受的时间内检出常规MRSI分辨率无法识别的多发性硬化代谢改变。

研究设计与样本

  • 前瞻性、经机构审查委员会批准的研究,纳入20例复发缓解型多发性硬化患者(9女/11男,平均年龄±标准差30.8±7.7岁),比较自由感应衰减MRSI在3种空间分辨率(2.2×2.2×8 mm、3.4×3.4×8 mm、6.8×6.8×8 mm体素,对应矩阵100×100、64×64、32×32)下的病灶代谢模式,并行成像加速,数据质量以信噪比和Cramér-Rao下界评估。

诊断标准与关键数值

  • 共分析77个T2高信号多发性硬化病灶(中位体积155.7 mm,范围10.8至747.0 mm);100×100分辨率下83%病灶显示肌醇/NAA升高,64×64为66%,32×32为35%;100×100较32×32平均代谢比值高40%至80%、最大代谢比值增100%至150%;3种分辨率两两比较平均代谢比值差异均有统计学意义(P<0.001);100×100下信噪比>12、Cramér-Rao下界<20%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to assess the utility of increased spatial resolution of magnetic resonance spectroscopic imaging (MRSI) at 7 T for the detection of neurochemical changes in multiple sclerosis (MS)-related brain lesions.

MATERIALS AND METHODS: This prospective, institutional review board-approved study was performed in 20 relapsing-remitting MS patients (9 women/11 men; mean age ± standard deviation, 30.8 ± 7.7 years) after receiving written informed consent. Metabolic patterns in MS lesions were compared at 3 different spatial resolutions of free induction decay MRSI with implemented parallel imaging acceleration: 2.2 × 2.2 × 8 mm; 3.4 × 3.4 × 8 mm; and 6.8 × 6.8 × 8 mm voxel volumes, that is, matrix sizes of 100 × 100, 64 × 64, and 32 × 32, respectively. The quality of data was assessed by signal-to-noise ratio and Cramér-Rao lower bounds. Statistical analysis was performed using Wilcoxon signed-rank tests with correction for multiple testing.

RESULTS: Seventy-seven T2-hyperintense MS lesions were investigated (median volume, 155.7 mm; range, 10.8-747.0 mm). The mean metabolic ratios in lesions differed significantly between the 3 MRSI resolutions (ie, 100 × 100 vs 64 × 64, 100 × 100 vs 32 × 32, and 64 × 64 vs 32 × 32; P < 0.001). With the ultra-high resolution (100 × 100), we obtained 40% to 80% higher mean metabolic ratios and 100% to 150% increase in maximum metabolic ratios in the MS lesions compared with the lowest resolution (32 × 32), while maintaining good spectral quality (signal-to-noise ratio >12, Cramér-Rao lower bounds <20%) and measurement time of 6 minutes. There were 83% of MS lesions that showed increased myo-inositol/N-acetylaspartate with the 100 × 100 resolution, but only 66% were distinguishable with the 64 × 64 resolution and 35% with the 32 × 32 resolution.

CONCLUSIONS: Ultra-high-resolution MRSI (~2 × 2 × 8 mm voxel volume) can detect metabolic alterations in MS, which cannot be recognized by conventional MRSI resolutions, within clinically acceptable time.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Heckova E, Strasser B, Hangel GJ, et al. 7 T Magnetic Resonance Spectroscopic Imaging in Multiple Sclerosis: How Does Spatial Resolution Affect the Detectability of Metabolic Changes in Brain Lesions? Invest Radiol. 2019. PMID: 30433892. doi:10.1097/RLI.0000000000000531

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。